---
title: "LABT.US (LABT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LABT.US/news.md"
symbol: "LABT.US"
name: "LABT.US"
parent: "https://longbridge.com/en/quote/LABT.US.md"
datetime: "2026-05-20T22:48:14.384Z"
locales:
  - [en](https://longbridge.com/en/quote/LABT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LABT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LABT.US/news.md)
---

# LABT.US (LABT.US) — Related News

### [Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update](https://longbridge.com/en/news/286788461.md)
*2026-05-18T14:11:00.000Z*
> Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) shares fell 22.67% to $1.15 despite announcing positive manufacturing

### [Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers | LABT Stock News](https://longbridge.com/en/news/286767867.md)
*2026-05-18T04:05:27.000Z*
> Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabeti

### [Lakewood-Amedex (LABT.US) Surges 25% Intraday](https://longbridge.com/en/news/284912994.md)
*2026-05-01T15:01:53.000Z*
> Lakewood-Amedex 生物治疗公司（LABT.US）现价 $3.340，当日 +25.56%，盘中短线涨幅显著，市值 0.00 亿。公司专注于生物治疗领域，盘中异动或与董事会新成员 Joseph Tucker 博士加入有关。近期公

### [Lakewood-Amedex Soars Over 53% Amid Board Appointment](https://longbridge.com/en/news/284904614.md)
*2026-05-01T13:39:56.000Z*
> Lakewood-Amedex Biotherapeutics（LABT.US）现价 $4.088，当日 +53.68%，盘中震荡拉升，市值暂无数据。公司聚焦生物治疗领域，股价大涨与 Joseph Tucker 博士加入董事会相关。近期无其

### [Pre-market hot trades in US stocks: Lakewood-Amedex Biotherapeutics up 54.51% in pre-market; Galaxy Digital up 3.00% in pre-market](https://longbridge.com/en/news/284895286.md)
*2026-05-01T12:08:01.000Z*
> Lakewood-Amedex Biotherapeutics pre-market up 54.51%; Galaxy Digital pre-market up 3.00%; Cue BioPharma pre-market up 86

### [Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors | ENVB Stock News](https://longbridge.com/en/news/284375372.md)
*2026-04-28T03:33:00.000Z*
> Lakewood-Amedex Biotherapeutics has appointed Joseph Tucker, Ph.D., CEO of Enveric Biosciences, to its Board of Director